DK0804200T3 - Anvendelse af noribogain-derivater til behandling af kemisk afhængighed hos pattedyr - Google Patents
Anvendelse af noribogain-derivater til behandling af kemisk afhængighed hos pattedyrInfo
- Publication number
- DK0804200T3 DK0804200T3 DK95927295T DK95927295T DK0804200T3 DK 0804200 T3 DK0804200 T3 DK 0804200T3 DK 95927295 T DK95927295 T DK 95927295T DK 95927295 T DK95927295 T DK 95927295T DK 0804200 T3 DK0804200 T3 DK 0804200T3
- Authority
- DK
- Denmark
- Prior art keywords
- noribogain
- mammals
- derivatives
- treatment
- chemical dependence
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title 1
- 206010013663 drug dependence Diseases 0.000 title 1
- 208000011117 substance-related disease Diseases 0.000 title 1
- RAUCDOKTMDOIPF-UHFFFAOYSA-N hydroxyibogamine Natural products CCC1CC(C2)CC3C1N2CCC1=C3NC2=CC=C(O)C=C12 RAUCDOKTMDOIPF-UHFFFAOYSA-N 0.000 abstract 3
- -1 noribogaine compound Chemical class 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- RAUCDOKTMDOIPF-RYRUWHOVSA-N noribogaine Chemical compound N1([C@@H]2[C@H]3C[C@H](C1)C[C@@H]2CC)CCC1=C3NC2=CC=C(O)C=C12 RAUCDOKTMDOIPF-RYRUWHOVSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28018794A | 1994-07-25 | 1994-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0804200T3 true DK0804200T3 (da) | 2006-09-11 |
Family
ID=23072046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95927295T DK0804200T3 (da) | 1994-07-25 | 1995-07-25 | Anvendelse af noribogain-derivater til behandling af kemisk afhængighed hos pattedyr |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6348456B1 (fr) |
| EP (1) | EP0804200B1 (fr) |
| AT (1) | ATE324897T1 (fr) |
| AU (1) | AU4613296A (fr) |
| DE (1) | DE69534975T2 (fr) |
| DK (1) | DK0804200T3 (fr) |
| ES (1) | ES2264562T3 (fr) |
| IL (1) | IL114726A (fr) |
| MX (1) | MX9701430A (fr) |
| PT (1) | PT804200E (fr) |
| WO (1) | WO1996003127A1 (fr) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220737B1 (en) | 1997-09-04 | 2007-05-22 | Novoneuron, Inc | Noribogaine in the treatment of pain and drug addiction |
| AU2003200404B2 (en) * | 1997-09-04 | 2006-06-29 | Demerx, Inc. | Noribogaine in the treatment of pain and drug addiction |
| ES2395268T3 (es) * | 1997-09-04 | 2013-02-11 | Demerx, Inc. | Noribogaína para el tratamiento del dolor y la drogadicción |
| BR0106261A (pt) * | 2001-12-26 | 2003-09-02 | Fundacao Oswaldo Cruz | Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids |
| US20030153552A1 (en) * | 2002-02-14 | 2003-08-14 | Mash Deborah C. | Method of treating chemical dependency in mammals and a composition therefor |
| GB2480632A (en) | 2010-05-25 | 2011-11-30 | Kythera Biopharmaceuticals Inc | Preparation of 12-keto and 12-alpha-hydroxy steroids |
| US8765737B1 (en) | 2010-05-11 | 2014-07-01 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
| US9394294B2 (en) | 2010-05-11 | 2016-07-19 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
| US8362007B1 (en) | 2010-05-11 | 2013-01-29 | Demerx, Inc. | Substituted noribogaine |
| US8741891B1 (en) | 2010-06-22 | 2014-06-03 | Demerx, Inc. | N-substituted noribogaine prodrugs |
| US8637648B1 (en) | 2010-06-22 | 2014-01-28 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| US8802832B2 (en) | 2010-06-22 | 2014-08-12 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| US9586954B2 (en) | 2010-06-22 | 2017-03-07 | Demerx, Inc. | N-substituted noribogaine prodrugs |
| AU2012202509B2 (en) * | 2010-07-23 | 2014-02-13 | Demerx, Inc. | Noribogaine compositions |
| US9358237B2 (en) | 2010-07-23 | 2016-06-07 | Demerx, Inc. | Noribogaine compositions |
| EP2481740B1 (fr) | 2011-01-26 | 2015-11-04 | DemeRx, Inc. | Procédés et compositions pour préparer de la noribogaïne à partir de voacangine |
| US9617274B1 (en) | 2011-08-26 | 2017-04-11 | Demerx, Inc. | Synthetic noribogaine |
| AU2012308274B2 (en) * | 2011-09-15 | 2017-08-17 | Demerx, Inc. | Noribogaine salt ansolvates |
| CA2856551C (fr) | 2011-12-08 | 2021-06-22 | Robert M. Moriarty | Synthese stereoselective totale de la noribogaine |
| EP2788003A4 (fr) | 2011-12-09 | 2015-05-27 | Demerx Inc | Esters phosphoriques de noribogaïne |
| WO2013085849A2 (fr) * | 2011-12-09 | 2013-06-13 | Demerx, Inc. | Esters de sulfate de noribogaïne |
| US9150584B2 (en) | 2012-01-25 | 2015-10-06 | Demerx, Inc. | Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them |
| WO2013112163A1 (fr) * | 2012-01-25 | 2013-08-01 | Demerx, Inc. | Dérivés d'isoquinuclidène fusionnés à de l'indole et du benzofurane et procédés de préparation de ceux-ci |
| CA2858820C (fr) | 2012-01-25 | 2021-08-17 | Demerx, Inc. | Voacangine synthetique |
| CA2896133A1 (fr) | 2012-12-20 | 2014-06-26 | Demerx, Inc. | Noribogaine substituee |
| US9045481B2 (en) | 2012-12-20 | 2015-06-02 | Demerx, Inc. | Substituted noribogaine |
| US8940728B2 (en) | 2012-12-20 | 2015-01-27 | Demerx, Inc. | Substituted noribogaine |
| CA3256416A1 (fr) * | 2013-03-15 | 2025-06-21 | Demerx, Inc. | Procédé pour le traitement avec la noribogaïne de l’addiction de patients sous méthadone |
| AU2014379612A1 (en) * | 2014-01-24 | 2016-08-11 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| US9561232B2 (en) | 2014-02-18 | 2017-02-07 | Demerx, Inc. | Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use |
| CA2977636C (fr) * | 2014-02-18 | 2024-01-02 | Demerx, Inc. | Methodes therapeutiques faisant intervenir de la noribogaine et des composes apparentes |
| AU2014383143A1 (en) | 2014-02-18 | 2016-09-29 | Demerx, Inc. | Methods for acute and long-term treatment of drug addiction |
| US9345711B2 (en) | 2014-02-18 | 2016-05-24 | Demerx, Inc. | Methods for acute and long-term treatment of drug addiction |
| US9591978B2 (en) | 2014-03-13 | 2017-03-14 | Demerx, Inc. | Methods and compositions for pre-screening patients for treatment with noribogaine |
| WO2015195673A2 (fr) | 2014-06-18 | 2015-12-23 | Demerx, Inc. | Dérivés d'indole et de benzofurane halogénés d'isoquinuclidène et procédés pour leur préparation. |
| US9549935B2 (en) | 2014-07-14 | 2017-01-24 | Demerx, Inc. | Methods and compositions for treating migraines using noribogaine |
| EP3845275A1 (fr) | 2014-11-26 | 2021-07-07 | DemeRx, Inc. | Procédés et compositions pour potentialiser l'action d'analgésiques opioïdes en utilisant des alcaloïdes de l'iboga |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| CA3138094A1 (fr) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Procedes de traitement des troubles de l'anxiete, des troubles de la cephalee et des troubles de l'alimentation au moyen de psilocybine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3516989A (en) * | 1967-10-02 | 1970-06-23 | American Home Prod | Intermediates for total synthesis of iboga alkaloids and means of preparation |
| US4499096A (en) * | 1983-11-18 | 1985-02-12 | Lotsof Howard S | Rapid method for interrupting the narcotic addiction syndrome |
| US4587243A (en) * | 1985-07-15 | 1986-05-06 | Lotsof Howard S | Rapid method for interrupting the cocaine and amphetamine abuse syndrome |
| US5152994A (en) * | 1990-05-31 | 1992-10-06 | Lotsof Howard S | Rapid method for interrupting or attenuating poly-drug dependency syndromes |
| US5591738A (en) * | 1994-10-14 | 1997-01-07 | Nda International, Inc. | Method of treating chemical dependency using β-carboline alkaloids, derivatives and salts thereof |
-
1995
- 1995-07-25 PT PT95927295T patent/PT804200E/pt unknown
- 1995-07-25 IL IL11472695A patent/IL114726A/en not_active IP Right Cessation
- 1995-07-25 AU AU46132/96A patent/AU4613296A/en not_active Abandoned
- 1995-07-25 DE DE69534975T patent/DE69534975T2/de not_active Expired - Lifetime
- 1995-07-25 DK DK95927295T patent/DK0804200T3/da active
- 1995-07-25 AT AT95927295T patent/ATE324897T1/de not_active IP Right Cessation
- 1995-07-25 ES ES95927295T patent/ES2264562T3/es not_active Expired - Lifetime
- 1995-07-25 MX MX9701430A patent/MX9701430A/es not_active IP Right Cessation
- 1995-07-25 WO PCT/US1995/009136 patent/WO1996003127A1/fr not_active Ceased
- 1995-07-25 EP EP95927295A patent/EP0804200B1/fr not_active Expired - Lifetime
-
1996
- 1996-10-08 US US08/727,123 patent/US6348456B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU4613296A (en) | 1996-04-19 |
| MX9701430A (es) | 1997-12-31 |
| EP0804200A1 (fr) | 1997-11-05 |
| EP0804200B1 (fr) | 2006-05-03 |
| EP0804200A4 (fr) | 1999-06-23 |
| DE69534975D1 (de) | 2006-06-08 |
| IL114726A (en) | 2002-04-21 |
| DE69534975T2 (de) | 2007-01-11 |
| IL114726A0 (en) | 1995-11-27 |
| ATE324897T1 (de) | 2006-06-15 |
| PT804200E (pt) | 2006-09-29 |
| US6348456B1 (en) | 2002-02-19 |
| ES2264562T3 (es) | 2007-01-01 |
| WO1996003127A1 (fr) | 1996-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0804200T3 (da) | Anvendelse af noribogain-derivater til behandling af kemisk afhængighed hos pattedyr | |
| MX154758A (es) | Procedimiento para preparacion de derivados de succinimida | |
| ID17851A (id) | Persenyawaan heterosiklis, produksi dan pemakaiannya | |
| TW370450B (en) | Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives | |
| DE3781716D1 (de) | Mittel zur ortsspezifischen alkylierung. | |
| HUP9903836A2 (hu) | Új eljárás Cox-2 inhibítor hatású fenil-szubsztituált 2(5H)-furanonok előállítására | |
| NZ503912A (en) | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists | |
| ATE263771T1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
| EP0945764A3 (fr) | Composition pour photoréserve | |
| EA200100310A1 (ru) | Кислородсодержащие гетероциклические соединения | |
| DK1447400T3 (da) | Bicyklisk forbindelse | |
| SE0003186D0 (sv) | New process | |
| JO2433B1 (en) | Preparation of heterocyclic lindane landscapes | |
| YU166291A (sh) | Indenoindol jedinjenja | |
| DE60004669D1 (de) | Indolocarbazolalkaloide aus einer marinen actinomycete | |
| BR9911402A (pt) | Uso de corantes amino azóicos, e, compostos | |
| DK0963998T3 (da) | Azasteroidforbindelse til behandling eller prævention af prostatacancer | |
| DE60007848D1 (de) | Herstellung von 2'-substitutierter rns | |
| TR199900922T2 (xx) | Lipoprotein (A)'n�n plazma seviyesini d���rmek i�in bir y�ntem. | |
| ATE231514T1 (de) | Substituierte isophosphindoline und ihre verwendung | |
| DE60114889D1 (de) | Verfahren zur herstellung von fluconazole und kristallmodifikationen davon | |
| EA199800931A1 (ru) | Способ получения ингибиторов фосфодиэстеразы iv | |
| WO2002100804A3 (fr) | Nouvelle utilisation d'acides sulfamiques comme agents de separation | |
| DE69903930D1 (de) | N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen | |
| FR2794122B1 (fr) | Nouveaux antioxydants, procedes de preparation et utilisations |